Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Anacor Pharmaceuticals Inc    ANAC   US0324201013

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/15/2014 10/16/2014 10/17/2014 10/20/2014 10/21/2014 Date
24.03(c) 24.81(c) 25.65(c) 27.42(c) 28.24(c) Last
1 104 713 579 519 473 070 637 223 537 077 Volume
+1.01% +3.25% +3.39% +6.90% +2.99% Change
More quotes
Company
Anacor Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform.The company has discovered seven compounds that are currently in development including its lead... 
Surperformance© rating of Anacor Pharmaceuticals Inc
Trading Rating : Investor Rating :
More about the company
Chart ANACOR PHARMACEUTICALS INC
Duration : Period :
Anacor Pharmaceuticals Inc Technical Analysis Chart | ANAC | US0324201013 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 14,7 M
EBIT 2014 -96,4 M
Net income 2014 -105 M
Debt 2014 -
Yield 2014 -
Sales 2015 26,1 M
EBIT 2015 -90,8 M
Net income 2015 -98,4 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 80,9x
Capi. / Sales 2015 45,4x
Capitalization 1 186 M
More Financials
Latest news on ANACOR PHARMACEUTICALS INC
6d ago ANACOR PHARMACEUTICALS : Entry into a Material Definitive Agreement, Creation of..
7d ago ANACOR PHARMACEUTICALS : Announces Pricing of Offering of $75 Million of 2.00% C..
7d ago ANACOR PHARMACEUTICALS : Announces Proposed Offering of $70 Million of Convertib..
10/10 ANACOR PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8..
10/09 ANACOR PHARMACEUTICALS : Announces Pricing of Offering of $75 Million of 2.00% C..
10/08 ANACOR PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8..
10/08 ANACOR PHARMACEUTICALS : Announces Proposed Offering of $70 Million of Convertib..
10/03 ANACOR PHARMACEUTICALS : Entry into a Material Definitive Agreement (form 8-K)
09/22 ANACOR PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8..
09/22 ANACOR PHARMACEUTICALS : Announces Commercial Launch of KERYDIN (tavaborole) Top..
09/12 ANACOR PHARMACEUTICALS : Change in Directors or Principal Officers, Financial St..
09/12 ANACOR PHARMACEUTICALS : Appoints Wendell Wierenga to Its Board of Directors
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF